| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christopher Heery | CHIEF MEDICAL OFFICER | 2026-01-14 | 5,882 | $68.51 | $403.00kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2026-01-13 | 7,437 | $65.51 | $487.21kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2026-01-12 | 6,131 | $64.15 | $393.29kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-11-17 | 340 | $90.00 | $30.60kSell |
| Michelle Gilson | CHIEF FINANCIAL OFFICER | 2025-10-15 | 5,364 | $91.04 | $488.32kSell |
| Michelle Gilson | CHIEF FINANCIAL OFFICER | 2025-10-06 | 1,064 | $86.22 | $91.73kSell |
| Michelle Gilson | CHIEF FINANCIAL OFFICER | 2025-10-03 | 4,882 | $86.00 | $419.87kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-09-30 | 1,530 | $82.20 | $125.76kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-09-30 | 5,300 | $80.55 | $426.93kSell |
| Christopher Heery | CHIEF MEDICAL OFFICER | 2025-09-30 | 14,204 | $81.46 | $1.16MSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gilead Sciences Inc | 11.62% | 6,720,803 | $463.33M | Insider |
| Gilead Sciences Inc | 11.62% | 6,720,803 | $463.33M | Institution |
| Sr One Capital Management LLC | 11.28% | 6,520,370 | $449.51M | Insider |
| T Rowe Price Investment Management Inc | 10.99% | 6,352,356 | $437.93M | Institution |
| Jill Carroll | 10.97% | 6,340,738 | $437.13M | Insider |
| Fmr LLC | 9.96% | 5,761,317 | $397.19M | Institution |
| Scott D. Sandell | 8.21% | 4,748,116 | $327.34M | Insider |
| Peter W. Sonsini | 8.21% | 4,746,083 | $327.19M | Insider |
| Mohamad Makhzoumi | 8.21% | 4,745,545 | $327.16M | Insider |
| Anthony A. Florence Jr. | 8.21% | 4,745,262 | $327.14M | Insider |